Fall Prediction Index for Patients in Stroke Rehabilitation
Stroke 28:716-721, Nyberg,L.&Gustafson,Y., 1997
Outcomes of Stroke Patients in Medicare Fee for Service and Managed Care
JAMA 278:119-124, 1611997., Retchin,S.M.,et al, 1997
Paramedian Pontine Infarction
Stroke 28:809-815, Kataoka,S.,et al, 1997
Characterizing the Target of Acute Stroke Therapy
Stroke 28:866-872, Fisher,M., 1997
Prognosis of Stroke Patients Requiring Mechanical Ventilation in a Neurological Critical Care Unit
Stroke 28:711-715, Steiner,T.,et al, 1997
Stroke Recurrence:Predictors, Severity, and Prognosis, The Copenhagen Stroke Study
Neurol 48:891-895, Jorgensen,H.S.,et al, 1997
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
NEJM 336:973-979, 1014-10161997., Ridker,P.M.,et al, 1997
Influence of Cholesterol on Survival After Stroke:Retrospective Study
BMJ 314:1584-1588, Dyker,A.G.,et al, 1997
Practice Guidelines for the Use of Imaging in Transient Ischemic Attacks and Acute Stroke
Stroke 28:1480-1497, Culebras,A.,et al, 1997
CAG Repeat Number Governs the Development Rate of Pathology in Huntington's Disease
Ann Neurol 41:689-692, Penney,J.B.,et al, 1997
Clinicopath Conf
Progressive Supranuclear Palsy, Case 26, 1997, NEJM 337:549-55697., , 1997
Long-Term Cognitive Impairment Associated with Caudate Stroke
Stroke 28:970-975, Bokura,H.&Robinson,R.G., 1997
Doctors & Pts Don't Agree:Cross Sectional Study of Pts' & Doctors'Perceptions & Assessments of Disability in MS
BMJ 314:1580-1583, Rothwell,P.M.,et al, 1997
The Impact of Inpatient Rehabilitation on Progressive Multiple Sclerosis
Ann Neurol 42:236-244, Freeman,J.A.,et al, 1997
Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997
Serial Neuropsychological Assess & Magnetic Resonance Imagingf Analysis in Multiple Sclerosis
Arch Neurol 54:1018-1025, Hohol,M.J.,et al, 1997
Leukodystrophy in Patients with Ovarian Dysgenesis
Ann Neurol 41:654-661, Schiffman,R.,et al, 1997
Donepezil (Aricept) for Alzheimer's Disease
The Medical Letter 39:53-54, , 1997
Prevalence and Severity of Cognitive Impairment with and without Dementia in an Elderly Population
Lancet 349:1793-1796, Graham,J.E.,et al, 1997
Increased Risk of Mortality in Alzheimer's Disease Patients with Higher Education
Neurol 49:798-802, Geerlings,M.I.,et al, 1997
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
NEJM 336:1216-1222, 12451997., Sano,M.,et al, 1997
Antioxidants and Dementia
Lancet 349:1189-1190, Lethem,R.&Orrell,M., 1997
Reliability of Wash Univ Road Test:A Performance-Based Assess for Drivers with Dementia of Alzheimer Type
Arch Neurol 54:707-712, Hunt,L.A.,et al, 1997
Midline Cerebral Morphometry Distinguishes Frontotemporal Dementia and Alzheimer's Disease
Neurol 48:978-985, Kaufer,D.I.,et al, 1997
Simulated Car Crashes and Crash Predictors in Drivers with Alzheimer Disease
Arch Neurol 54:545-551, Rizzo,M.,et al, 1997
The Family Caregiver's Role in Alzheimer's Disease
Neurol 48 (Suppl 6) :S25-S29997., Haley,W.E., 1997
Cognitive Function and The costs of Alzheimer Disease
Arch Neurol 54:687-683, Ernst,R.L.,et al, 1997
Clinical Characteristics of a Chromosome 17-Linked Rapidly Progressive Familial Frontotemporal Dementia
Arch Neurol 54:539-544, Basun,H.,et al, 1997
Frontotemporal Dementia and Early Alzheimer Disease:Differentiation with Frontal Lobe H-1 MR Spectroscopy
Radiology 203:829-836, Ernst,T.,et al, 1997
Persistent Vegetative State
Lancet 350:795-799, Zeman,A., 1997
Olfactory Dysfunction in Patients with Head Trauma
Arch Neurol 54:1131-1140, Doty,R.L.,et al, 1997
A 44-Month Clinical-Brain MRI Follow-Up in a Patient with B12 Deficiency
Neurol 49:878-881, Stojsavljevic,N.,et al, 1997
Sympathetic Cardioneuropathy in Dysautonomias
NEJM 336:696-702, 7211997., Goldstein,D.S.,et al, 1997
Cerebrospinal Fluid Creatine Kinase BB Isoenzyme Activity & Neurol Prog after Cardiac Arrest
Neurol 48:352-357, Tirschwell,D.L.,et al, 1997
Cerebral Hemispheric Low-Flow Infarcts in Arterial Occlusive Disease:Lesion Patterns and Angiomorphological Conditions
Stroke 28:118-123, Mull,M.,et al, 1997
Outcomes and Costs After Hip Fracture and Stroke, A Comparison of Rehab Settings
JAMA 277:396-404, Kramer,A.M.,et al, 1997
Familial Intracranial Aneurysms
Lancet 349:380-384, Ronkainen,A.,et al, 1997
Intracranial Aneurysms
NEJM 336:28-40, Schievink,W.I., 1997
Unruptured Intracranial Vertebral Artery Dissection, Clin Course & Serial Radiographic Imagings
Stroke 28:370-374, Yoshimoto,Y.&Wakai,S., 1997
Anticardiolipin Antibodies & the Risk of Recurrent Thrombo-Occlusive Events & Death
The Antiphospholipid Antibodies & Stroke Study Group, Neurol 48:91-9497., , 1997
Acute Ischemic Strokes Improving During the First 48 Hours of Onset:Predictability, Outcome & Possible Mechanisms
Stroke 28:10-14, Toni,D.,et al, 1997
Prevalence and Risk Factors of Incontinence After Stroke:The Copenhagan Stroke Study
Stroke 28:58-62, Nakayama,H.,et al, 1997
High-Density Lipoprotein Cholesterol & Risk of Ischemic Stroke Mortality:21-Yr FU of 8586 Men-Israeli Ischemic Heart Dis Study
Stroke 28:83-87, Tanne,D.,et al, 1997
High Incidence of Pneumonia in Elderly Patients with Basal Ganglia Infarction
Arch Int Med 157:321-324, Nakagawa,T.,et al, 1997
The Natural Course of Cerebral Lesions in Sneddon Syndrome
Arch Neurol 54:53-60, Tourbah,A.,et al, 1997
Progression of Ischaemic Stroke and Excitotoxic Aminoacids
Lancet 349:79-83, Castillo,J.,et al, 1997
Atrial Fibrillation and Stroke, Mortality & Causes of Death AFter the First Acute Ischemic Stroke
Stroke 28:311-315, Kasrisalo,M.M.,et al, 1997
Early Hemorrhage Growth in Patients with Intracerebral Hemorrhage
Stroke 28:1-5, Brott,T.,et al, 1997
Atrial Fibrillation and Dementia in a Population-Based Study, The Rotterdam Study
Stroke 28:316-321, Ott,A.,et al, 1997
Association of Tuberous Sclerosis of Temporal Lobes with Autism and Atypical Autism
Lancet 349:392-395, Bolton,P.F.&Griffiths,P.D., 1997